Additional file 2: of Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink

Figure S2. Relationship between change in weight at 18 months and baseline weight according to second-line treatment. Scatter plots of baseline (index) weight against change in weight at 18 months in patients on metformin plus either an SU (a), a DPP-4 inhibitor, (b) an SGLT-2 inhibitor (c), or other therapies (d). Regression lines are shown as grey dashed lines, and their corresponding gradient slopes (m) were calculated for baseline weight. (TIF 3255 kb)